| Methods | Design: RCT |
| Unit of randomisation: Individually randomised trial | |
| Participants | Location/Setting: State run school in Pune, India |
| Sample size: 50 adolescent girls | |
| Dropouts/withdrawals: 1 out of 50 loss to follow‐up | |
| Sex: Only adolescent post menarchal girls | |
| Mean age: 14.6 years | |
| Inclusion criteria: Post Menarche adolescent girls | |
| Exclusion criteria: Not specified | |
| Interventions | Intervention (sample size): |
| Group 1 (N = 25): Subjects in the treatment group were administered 6 vitamin D2 (Ergocalciferol; Celltech, UK) tablets each containing 1.25 mg | |
| (50,000 IU) orally at 1, 4, 7 and 10 months | |
| Control (sample size): | |
| Group 2 (N = 25): Placebo group the local pharmacist prepared tablets which were identical in number, colour, size and texture to the ergocalciferol, but contained only sucrose | |
| The intervention was provided for a duration of one year and all participants received 250 mg elemental calcium (calcium carbonate) daily | |
| Outcomes | Primary outcomes: Total body bone mineral content, Lumbar spine bone mineral content and lumbar spine bone mineral apparent density |
| Secondary outcomes: Total body lean, fat mass and serum concentrations of biochemical parameters | |
| Timing of outcome assessment: After one year of intervention | |
| Notes | Study start date: February 2006 |
| Study end date: April 2007 | |
| Funding source: Not specified | |
| Conflicts of interest: None declared |